1
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency as Open Label Extension
Condition(s):XIAP Deficiency; NLRC4-MASLast Updated:July 22, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):XIAP Deficiency; NLRC4-MASLast Updated:July 22, 2022Recruiting
Condition(s):NLRC4-MAS; XIAP DeficiencyLast Updated:March 10, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.